Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Antimicrobial peptide discovery is challenged by the astronomical size of
peptide space and the relative scarcity of active peptides. Generative models
provide continuous latent "maps" of peptide space, but conventionally ignore
decoder-induced geometry and rely on flat Euclidean metrics, rendering
exploration and optimization distorted and inefficient. Prior manifold-based
remedies assume fixed intrinsic dimensionality, which critically fails in
practice for peptide data. Here, we introduce PepCompass, a geometry-aware
framework for peptide exploration and optimization. At its core, we define a
Union of $\kappa$-Stable Riemannian Manifolds $\mathbb{M}^{\kappa}$, a family
of decoder-induced manifolds that captures local geometry while ensuring
computational stability. We propose two local exploration methods: Second-Order
Riemannian Brownian Efficient Sampling, which provides a convergent
second-order approximation to Riemannian Brownian motion, and Mutation
Enumeration in Tangent Space, which reinterprets tangent directions as discrete
amino-acid substitutions. Combining these yields Local Enumeration Bayesian
Optimization (LE-BO), an efficient algorithm for local activity optimization.
Finally, we introduce Potential-minimizing Geodesic Search (PoGS), which
interpolates between prototype embeddings along property-enriched geodesics,
biasing discovery toward seeds, i.e. peptides with favorable activity. In-vitro
validation confirms the effectiveness of PepCompass: PoGS yields four novel
seeds, and subsequent optimization with LE-BO discovers 25 highly active
peptides with broad-spectrum activity, including against resistant bacterial
strains. These results demonstrate that geometry-informed exploration provides
a powerful new paradigm for antimicrobial peptide design.
Key Contributions
Introduces PepCompass, a geometry-aware framework for peptide exploration and optimization that accounts for decoder-induced geometry using Riemannian manifolds. It proposes novel exploration methods that are more efficient and accurate than traditional flat Euclidean metrics, addressing limitations of fixed intrinsic dimensionality assumptions.
Business Value
Accelerates the discovery of novel antimicrobial peptides, potentially leading to new therapeutic agents and reducing the time and cost associated with traditional drug discovery pipelines.